8
Participants
Start Date
August 19, 2020
Primary Completion Date
March 29, 2022
Study Completion Date
May 4, 2022
13C-MRS procedure/Acetate infusion
Glial metabolism will be measured via MRS utilizing a simultaneous intravenous infusion of 13C labeled acetate. An intravenous catheter will be placed in a vein of each arm, one to infuse 13C-acetate and the other to draw blood samples.
Continuous glucose monitoring
Participants will wear blinded continuous glucose monitoring devices (dexcom, G6) for approximately 4 weeks. Sensors will be replaced every 7-10 days.
Tulane Medical Center, New Orleans
Pennington Biomedical Research Center, Baton Rouge
Pennington Biomedical Research Center
OTHER